Mark Herrmann has details of Sinclair v. Merck. The decision also suggests that the New Jersey Supreme Court is going to affirm the intermediate McDarby decision rejecting the use of consumer-fraud law for product-liability claims in New Jersey.
Chronicling the high cost of our legal system
by Ted Frank on June 4, 2008
Mark Herrmann has details of Sinclair v. Merck. The decision also suggests that the New Jersey Supreme Court is going to affirm the intermediate McDarby decision rejecting the use of consumer-fraud law for product-liability claims in New Jersey.
Tagged as: class actions, medical monitoring, New Jersey, pharmaceuticals, Vioxx

Get smart with the Thesis WordPress Theme from DIY Themes.